SCHEMBL11965099

SCHEMBL11965099

Cc1cc2c(s1)-c1ccccc1OC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
HPGD P15428 8/20 0.60
GAA P10253 7/20 0.60
KDM4E B2RXH2 6/20 0.60
HSD17B10 Q99714 5/20 0.60
MAPK1 P28482 3/20 0.60
NOTUM Q6P988 1/20 0.60
GLA P06280 3/20 0.58
CASP1 P29466 3/20 0.58
CASP7 P55210 3/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
TSHR P16473 1/20 0.58
ATM Q13315 1/20 0.58
PIK3CA P42336 6/20 0.53
MAPT P10636 9/20 0.52
TP53 P04637 4/20 0.52
HTT P42858 3/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11965098 0.80 KDM4E (0.65) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL11965100 0.77 MAPT (0.46) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL12719338 0.77 ALDH1A1 (0.77) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL20991197 0.77 KDM4E (0.34) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL15274291 0.75 MAOA (0.42) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL11965072 0.75 KDM4E (0.56) ALDH1A1HPGDGAAKDM4ENOTUM
SCHEMBL987936 0.75 ALDH1A1 (1.00) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL17339839 0.74 NOTUM (0.36) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL20597096 0.74 NOTUM (0.78) ALDH1A1HPGDGAAKDM4EHSD17B10
SCHEMBL21257771 0.74 ALDH1A1 (0.73) ALDH1A1HPGDGAAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9624238-B2 4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use LEXICON PHARMACEUTICALS, INC. (US) 2017-04-18 US disclosed
US-20140256784-A1 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE OXFORD FINANCE LLC, AS COLLATERAL AGENT 2014-09-11 US disclosed
US-20120302562-A1 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS, INC. 2012-11-29 US disclosed
US-20120202794-A1 COMPOUNDS PHARMASSET, INC. (US) 2012-08-09 US disclosed
US-20120202794-A1 COMPOUNDS PHARMASSET, INC. (US) 2012-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202794-A1 COMPOUNDS HAVCR2, MAVS, GOT2 ALDH1A1 253/4885HPGD 2240/4885GAA 231/4885
US-20140256784-A1 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE NOTUM, CES1, ACHE ALDH1A1 1022/4885HPGD 521/4885GAA 94/4885
US-20120302562-A1 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE NOTUM, CES1, ACHE ALDH1A1 1022/4885HPGD 521/4885GAA 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.